Scientists have identified 50 new gene regions that increase the risk of developing schizophrenia, a finding that could lead to improved treatment for the debilitating psychiatric condition that affects over 20 million people worldwide.
The study showed that some of the genes identified as increasing risk for schizophrenia have previously been associated with other neurodevelopmental disorders, including intellectual disability and autism spectrum disorders.
"These findings are another important step on the long road to new treatments for schizophrenia and will be crucial for identifying potential new drugs, which will become an increasing focus of our work in the coming years," said Mike Owen, Professor at the Cardiff University.
For the study, published in the journal Nature Genetics, the team examined genetic data in 100,000 individuals including 40,000 people with a diagnosis of schizophrenia.
They also found that the genes linked to schizophrenia risk are mostly crucial to normal development and therefore typically do not contain harmful mutations.
This discovery will help researchers narrow down their search for the mechanisms of the disorder as these genes, commonly called "loss-of-function intolerant", only account for around 15 per cent of all the genes in the human genome.
"We show, for the first time, that genetic variants that do not severely impact gene function, but presumably have a more subtle impact on these critical genes, increase risk for developing schizophrenia," said Antonio Pardinas, from the varsity.
Moreover, the findings have solved a mystery that puzzled psychiatrists and evolutionary geneticists -- why does schizophrenia affect so many people when on average they have fewer children than people without the disorder?
"We found that many gene variants linked to schizophrenia reside in regions of the genome in which natural selection is not very effective in the first place," explained James Walters, another researcher from the varsity.
"Also, most of them do not have individually serious effects, and this makes them less likely to be selected, either for or against," he noted.
--IANS
rt/nks/dg
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
